GB202003867D0 - Treatment of limbl spasticity - Google Patents
Treatment of limbl spasticityInfo
- Publication number
- GB202003867D0 GB202003867D0 GBGB2003867.5A GB202003867A GB202003867D0 GB 202003867 D0 GB202003867 D0 GB 202003867D0 GB 202003867 A GB202003867 A GB 202003867A GB 202003867 D0 GB202003867 D0 GB 202003867D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- limbl
- spasticity
- treatment
- limbl spasticity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2003867.5A GB202003867D0 (en) | 2020-03-17 | 2020-03-17 | Treatment of limbl spasticity |
PCT/GB2021/050647 WO2021186160A2 (en) | 2020-03-16 | 2021-03-16 | Treatment of limb spasticity |
US17/911,538 US20230248811A1 (en) | 2020-03-16 | 2021-03-16 | Treatment of Limb Spasticity |
AU2021238924A AU2021238924A1 (en) | 2020-03-16 | 2021-03-16 | Modified botulinum neurotoxin for treating limb spasticity |
CA3166885A CA3166885A1 (en) | 2020-03-16 | 2021-03-16 | Treatment of limb spasticity |
KR1020227035397A KR20220154738A (en) | 2020-03-16 | 2021-03-16 | Modified botulinum neurotoxin for treating limb spasticity |
BR112022018456A BR112022018456A2 (en) | 2020-03-16 | 2021-03-16 | LIMB SPASTICITY TREATMENT |
CN202180021570.7A CN115297887A (en) | 2020-03-16 | 2021-03-16 | Modified botulinum neurotoxin for use in the treatment of limb spasms |
JP2022555812A JP2023517724A (en) | 2020-03-16 | 2021-03-16 | A modified botulinum neurotoxin for the treatment of limb spasticity |
EP21713107.7A EP4121100A2 (en) | 2020-03-16 | 2021-03-16 | Modified botulinum neurotoxin for treating limb spasticity |
TW110109318A TWI825396B (en) | 2020-03-16 | 2021-03-16 | Treatment of limb spasticity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2003867.5A GB202003867D0 (en) | 2020-03-17 | 2020-03-17 | Treatment of limbl spasticity |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202003867D0 true GB202003867D0 (en) | 2020-04-29 |
Family
ID=70453705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2003867.5A Ceased GB202003867D0 (en) | 2020-03-16 | 2020-03-17 | Treatment of limbl spasticity |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202003867D0 (en) |
-
2020
- 2020-03-17 GB GBGB2003867.5A patent/GB202003867D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3629774A4 (en) | Combination therapy for treatment of restenosis | |
EP4096703A4 (en) | Therapeutic uses of tirzepatide | |
GB202020573D0 (en) | Novel methods of therapy | |
IL266708A (en) | Combined cd6 and imipenem therapy for treatment of infectious diseases and related inflammatory processes | |
IL291146A (en) | Treatment of hidradenitis with jak inhibitors | |
GB202003867D0 (en) | Treatment of limbl spasticity | |
GB202020572D0 (en) | Novel methods of therapy | |
GB201907305D0 (en) | Treatment of conditions | |
GB202003803D0 (en) | Treatment of limb spasticity | |
GB202101251D0 (en) | Treatment of conditions | |
GB202206348D0 (en) | Treatment of limb spasticity | |
GB202118007D0 (en) | Methods of treatment | |
GB202118011D0 (en) | Methods of treatment | |
GB202118006D0 (en) | Methods of treatment | |
GB202108242D0 (en) | Methods of treatment | |
GB202108245D0 (en) | Methods of treatment | |
GB202005874D0 (en) | Methods of treatment | |
GB202315695D0 (en) | TReatment of cariomyopathy | |
GB202212506D0 (en) | Treatment of covid-19 | |
GB202102950D0 (en) | Method of treatment | |
GB201917253D0 (en) | Treatment of conditions | |
GB202018243D0 (en) | Method of treatment | |
GB202012436D0 (en) | Method of treatment | |
GB202006739D0 (en) | Method of treatment | |
GB202005015D0 (en) | Method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |